Skip to main content
. 2018 Aug 1;8(7):e021805. doi: 10.1136/bmjopen-2018-021805

Table 3.

Summary of exposure, covariate and outcome variables collected in the ProBe CaRe study

Exposures Outcome
Genetic variants Recurrence
ERα and ERβ Mortality
17βHSD1 and 17βHSD2
Biomarkers
Clinical Demographic
Tumour characteristics Age
Treatment therapy Region
Comorbidity Hospital of diagnosis
Medication history and use

ERα, oestrogen receptor alpha; ERβ, oestrogen receptor beta; 17β-hydroxysteroid dehydrogenase 1 and 2; ProBe CaRe, Predictors of Breast Cancer Recurrence.